78 related articles for article (PubMed ID: 23685346)
21. Novel triorganotin complexes based on phosphonic acid ligands: Syntheses, structures and in vitro cytostatic activity.
An BH; Zhang RF; Du XM; Li QL; Cheng S; Huang HL; Ma CL
J Inorg Biochem; 2020 May; 206():111022. PubMed ID: 32070916
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, characterization and biological activity of triorganotin 2-phenyl-1,2,3-triazole-4-carboxylates.
Tian L; Sun Y; Li H; Zheng X; Cheng Y; Liu X; Qian B
J Inorg Biochem; 2005 Aug; 99(8):1646-52. PubMed ID: 15967504
[TBL] [Abstract][Full Text] [Related]
23. Spectral analysis and in vitro cytotoxicity profiles of novel organotin(IV) esters of 2-maleimidopropanoic acid.
Khan MI; Baloch MK; Ashfaq M
J Enzyme Inhib Med Chem; 2007 Jun; 22(3):343-50. PubMed ID: 17674816
[TBL] [Abstract][Full Text] [Related]
24. Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition.
Shah RD; Jagtap JC; Mruthyunjaya S; Shelke GV; Pujari R; Das G; Shastry P
J Cell Biochem; 2013 Apr; 114(4):854-63. PubMed ID: 23097134
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic activity against a series of tumour cell lines of dimethyltin dichloride complexes with various donor ligands.
al-Allaf TA; Khuzaie RF; Rashan LJ; Halaseh WF
Boll Chim Farm; 1999 Jun; 138(6):267-71. PubMed ID: 10464976
[TBL] [Abstract][Full Text] [Related]
26. Tri- and diorganotin(IV) complexes of biologically important orotic acid: synthesis, spectroscopic studies, in vitro anti-cancer, DNA fragmentation, enzyme assays and in vivo anti-inflammatory activities.
Nath M; Vats M; Roy P
Eur J Med Chem; 2013 Jan; 59():310-21. PubMed ID: 23266665
[TBL] [Abstract][Full Text] [Related]
27. New organotin(IV) ascorbates: synthesis, spectral characterization, biological and potentiometric studies.
Nath M; Jairath R; Eng G; Song X; Kumar A
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):77-86. PubMed ID: 15556424
[TBL] [Abstract][Full Text] [Related]
28. Quantitative research of histone H3 acetylation levels of human hepatocellular carcinoma cells.
Wang W; Xu L; Kong J; Fan H; Yang P
Bioanalysis; 2013 Feb; 5(3):327-39. PubMed ID: 23394699
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
30. Diorganotin(IV) derivatives of substituted benzohydroxamic acids with high antitumor activity.
Li Q; da Silva MF; Pombeiro AJ
Chemistry; 2004 Mar; 10(6):1456-62. PubMed ID: 15034889
[TBL] [Abstract][Full Text] [Related]
31. Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib): preparation, structural characterization, antibacterial and antiproliferative activities of [(n-Bu)2 Sn(H(-1)L)] (LH=H-Aib-L-Leu-OH, H-Aib-L-Ala-OH).
Katsoulakou E; Tiliakos M; Papaefstathiou G; Terzis A; Raptopoulou C; Geromichalos G; Papazisis K; Papi R; Pantazaki A; Kyriakidis D; Cordopatis P; Manessi-Zoupa E
J Inorg Biochem; 2008 Jul; 102(7):1397-405. PubMed ID: 18289688
[TBL] [Abstract][Full Text] [Related]
32. Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3.
Oliveras-Ferraros C; Fernández-Arroyo S; Vazquez-Martin A; Lozano-Sánchez J; Cufí S; Joven J; Micol V; Fernández-Gutiérrez A; Segura-Carretero A; Menendez JA
Int J Oncol; 2011 Jun; 38(6):1533-47. PubMed ID: 21455577
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, characterization, antimicrobial and antitumor screening of some diorganotin(IV) complexes of 2-[(9H-Purin-6-ylimino)]-phenol.
Rehman W; Badshah A; Khan S; Tuyet le TA
Eur J Med Chem; 2009 Oct; 44(10):3981-5. PubMed ID: 19464768
[TBL] [Abstract][Full Text] [Related]
34. On the bioreactivity of triorganotin aminobenzoates. Investigation of trialkyl and triarylyltin(IV) esters of 3-amino and 4-aminobenzoic acids.
Tzimopoulos D; Sanidas I; Varvogli AC; Czapik A; Gdaniec M; Nikolakaki E; Akrivos PD
J Inorg Biochem; 2010 Apr; 104(4):423-30. PubMed ID: 20060169
[TBL] [Abstract][Full Text] [Related]
35. Syntheses, molecular structures, electrochemical behavior, theoretical study, and antitumor activities of organotin(IV) complexes containing 1-(4-chlorophenyl)-1-cyclopentanecarboxylato ligands.
Shang X; Meng X; Alegria EC; Li Q; Guedes da Silva MF; Kuznetsov ML; Pombeiro AJ
Inorg Chem; 2011 Sep; 50(17):8158-67. PubMed ID: 21793560
[TBL] [Abstract][Full Text] [Related]
36. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
Eikel D; Lampen A; Nau H
Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor gamma agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells.
Aouali N; Palissot V; El-Khoury V; Moussay E; Janji B; Pierson S; Brons NH; Kellner L; Bosseler M; Van Moer K; Berchem G
Br J Haematol; 2009 Dec; 147(5):662-71. PubMed ID: 19793255
[TBL] [Abstract][Full Text] [Related]
38. Identification of novel, selective, and stable inhibitors of class II histone deacetylases. Validation studies of the inhibition of the enzymatic activity of HDAC4 by small molecules as a novel approach for cancer therapy.
Ontoria JM; Altamura S; Di Marco A; Ferrigno F; Laufer R; Muraglia E; Palumbi MC; Rowley M; Scarpelli R; Schultz-Fademrecht C; Serafini S; Steinkühler C; Jones P
J Med Chem; 2009 Nov; 52(21):6782-9. PubMed ID: 19888759
[TBL] [Abstract][Full Text] [Related]
39. Valproic acid alters chromatin structure by regulation of chromatin modulation proteins.
Marchion DC; Bicaku E; Daud AI; Sullivan DM; Munster PN
Cancer Res; 2005 May; 65(9):3815-22. PubMed ID: 15867379
[TBL] [Abstract][Full Text] [Related]
40. [Modulation of histone acetylation and induction of apoptosis in SMMC-7721 cells by phenylhexyl isothiocyanate].
Lai YD; Ma XD; Huang YQ; Xu XN; Wang XZ; Chiao DJ; Liu D
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):804-7. PubMed ID: 21223683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
